Want to track RPRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 57 days
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
 RPRX Royalty Pharma plc 10 Feb 2026 (In 1 month) | | 1.31 | - |
| RPRX Royalty Pharma plc 5 Nov 2025 | | 1.04 | 1.17 |
| RPRX Royalty Pharma plc 4 Nov 2025 | | - | - |
| RPRX Royalty Pharma plc 7 Aug 2025 | | 1.04 | - |
| RPRX Royalty Pharma plc 7 May 2025 | | 0.95 | 1.06 |
| RPRX Royalty Pharma plc 13 Feb 2025 | | 1.05 | 1.15 |
| RPRX Royalty Pharma plc 6 Nov 2024 | | 0.93 | 1.01 |
| RPRX Royalty Pharma plc 6 Aug 2024 | | 0.99 | - |
| RPRX Royalty Pharma plc 6 Jun 2024 | | 0.98 | 0.98 |
| RPRX Royalty Pharma plc 15 Feb 2024 | | 1.01 | 1.15 |
| RPRX Royalty Pharma plc 8 Nov 2023 | | 0.76 | 0.79 |
| RPRX Royalty Pharma plc 31 Dec 2016 | | - | - |
RPRX Earnings Reports FAQ
What is the earnings per share (EPS) for RPRX?
The current EPS is 3.8.
What is the company's earnings growth rate?
Over the past 9 years, the earnings growth rate has been approximately 48.1%, reflecting the RPRX's performance and NASDAQ (NGS) market conditions.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-10, based on the RPRX's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 1.17 per share, reported on 2025-11-05. For dividend history, visit the RPRX Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 32.93, calculated based on the most recent stock price of $38.52.
2025 © Marketlog. All Rights Reserved.
